SDGR
Schrodinger, Inc.
+3.62 (+15.13%)27.55USD3.3M成交股數2.1B市值–本益比(近四季)8.1股價營收比+7.5%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 58.9M+8% | 58.6M-2% | 87.2M+147% | 54.3M+15% | 54.8M+50% | 59.6M-20% | 35.3M-17% | 47.3M+35% | 36.6M | 74.1M | 42.6M | 35.2M |
| 營業成本 | 26.5M | 29.0M | 29.9M | 26.3M | 28.6M | 28.4M | 17.6M | 16.0M | 17.7M | 16.6M | 18.9M | 21.4M |
| 毛利 | 32.4M+24% | 29.5M-5% | 57.3M+223% | 28.0M-11% | 26.2M+38% | 31.1M-46% | 17.7M-25% | 31.3M+127% | 18.9M | 57.6M | 23.6M | 13.8M |
| 毛利率 | 55.1% | 50.4% | 65.7% | 51.6% | 47.8% | 52.3% | 50.2% | 66.2% | 51.6% | 77.6% | 55.5% | 39.2% |
| 研發費用 | 41.0M | 43.8M | 41.4M | 42.8M | 43.1M | 45.8M | 51.0M | 50.8M | 50.6M | 51.5M | 46.8M | 42.7M |
| 銷售管理費用 | 22.7M | 22.9M | 22.7M | 21.7M | 25.2M | 25.8M | 24.8M | 23.5M | 25.5M | 25.7M | 23.9M | 23.2M |
| 營業利益 | −41.5M-21% | −48.8M-4% | −17.2M-75% | −45.9M-13% | −52.9M-22% | −50.9M+72% | −68.4M+22% | −52.7M-14% | −67.4M | −29.6M | −56.2M | −61.1M |
| 營業利益率 | -70.6% | -83.3% | -19.7% | -84.6% | -96.6% | -85.5% | -193.9% | -111.4% | -184.3% | -40.0% | -132.0% | -173.7% |
| 稅後淨利 | 6.0M-114% | −60.0M+0% | 32.5M-185% | −32.8M-39% | −43.2M-21% | −59.8M+95% | −38.1M-39% | −54.0M-1363% | −54.7M | −30.7M | −62.0M | 4.3M |
| 淨利率 | 10.1% | -102.5% | 37.3% | -60.4% | -78.8% | -100.4% | -108.1% | -114.2% | -149.5% | -41.4% | -145.7% | 12.2% |
| 稀釋 EPS | 0.08-114% | -0.81-1% | 0.45-187% | -0.45-39% | -0.59-22% | -0.82+100% | -0.52-40% | -0.74-1333% | -0.76 | -0.41 | -0.86 | 0.06 |
| 稀釋股數 | 75.8M | 74.0M | 73.4M | 73.6M | 73.4M | 73.1M | 72.8M | 72.7M | 72.3M | 75.0M | 71.9M | 75.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 288M | 260M | 231M | 172M | 220M | 326M | 160M | 108M | 130M | 155M | 249M | 286M |
| 應收帳款 | 21.4M | 27.3M | 83.0M | 29.4M | 10.1M | 20.3M | 13.3M | 11.8M | 19.8M | 66.0M | 19.9M | 9.7M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 640M | 634M | 726M | 654M | 688M | 743M | 669M | 688M | 738M | 803M | 794M | 842M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 311M | 321M | 362M | 332M | 345M | 370M | 220M | 214M | 224M | 254M | 231M | 230M |
| 股東權益 | 329M | 314M | 364M | 321M | 343M | 374M | 449M | 474M | 514M | 549M | 564M | 611M |
| 負債比 | 48.6% | 50.6% | 49.9% | 50.8% | 50.2% | 49.7% | 32.9% | 31.1% | 30.4% | 31.7% | 29.0% | 27.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −14.8M-110% | – | – | – | 144M | – | – | −39.3M | – | – | – |
| 資本支出 | – | 2.5M | – | – | – | 596K | – | – | 4.1M | – | – | – |
| 自由現金流 | – | −17.3M-112% | – | – | – | 143M | – | – | −43.4M | – | – | – |
| 折舊攤銷 | – | 1.5M | – | – | – | 1.6M | – | – | 1.4M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -29.6% | – | – | – | 240.9% | – | – | -118.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 256M
| Software Products And Services | 200M | 78.0% | +10.6% |
|---|---|---|---|
| Drug Discovery | 56.4M | 22.0% | +107.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 256M | +23.3% | −103M | -40.4% | -1.41 | 12.5M |
| FY2024 | 208M | -4.2% | −187M | -90.2% | -2.57 | −165M |
| FY2023 | 217M | +19.7% | 40.7M | 18.8% | 0.54 | −150M |
| FY2022 | 181M | +31.2% | −149M | -82.4% | -2.10 | −128M |
| FY2021 | 138M | +27.6% | −101M | -73.4% | -1.42 | −77.8M |
| FY2020 | 108M | +26.4% | −24.5M | -22.6% | -0.41 | 14.2M |
| FY2019 | 85.5M | – | −24.6M | -28.7% | -4.09 | −27.9M |